Cargando…
Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case
Liver abscess formation is one of the major complications following radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC). Clostridium perfringens is a rare but fatal (mortality rate: 70–100%) organism that could lead to severe sepsis. We presented a case where a 63-year-old...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261265/ https://www.ncbi.nlm.nih.gov/pubmed/34267637 http://dx.doi.org/10.1159/000517024 |
_version_ | 1783718978643820544 |
---|---|
author | Wang, Ming-Hung Kuo, Yuan-Hung Yen, Yi-Hao Lu, Sheng-Nan Wang, Jing-Houng Chen, Chien-Hung Hung, Chao-Hung Kee, Kwong-Ming |
author_facet | Wang, Ming-Hung Kuo, Yuan-Hung Yen, Yi-Hao Lu, Sheng-Nan Wang, Jing-Houng Chen, Chien-Hung Hung, Chao-Hung Kee, Kwong-Ming |
author_sort | Wang, Ming-Hung |
collection | PubMed |
description | Liver abscess formation is one of the major complications following radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC). Clostridium perfringens is a rare but fatal (mortality rate: 70–100%) organism that could lead to severe sepsis. We presented a case where a 63-year-old woman with diabetes mellitus, hypertension, chronic hepatitis B-related cirrhosis in Child-Pugh class A and HCC with initial TNM stage II who had undergone 2 sessions of transarterial chemoembolization. RFA was performed for 4 small HCC due to poor effect of previous transarterial chemoembolization. However, all 4 treated tumors developed liver abscesses presenting with septic shock within 1 day. Aspirated abscesses and blood culture both yielded C. perfringens infection. After intensive care, optimal intravenous antibiotic, and abscesses aspiration, the patient recovered successfully. All tumors achieved complete response during the follow-up period without local recurrence. The clinical presentations and risk factors of C. perfringens−related liver abscess after RFA will be discussed in this manuscript. |
format | Online Article Text |
id | pubmed-8261265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-82612652021-07-14 Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case Wang, Ming-Hung Kuo, Yuan-Hung Yen, Yi-Hao Lu, Sheng-Nan Wang, Jing-Houng Chen, Chien-Hung Hung, Chao-Hung Kee, Kwong-Ming Case Rep Oncol Case Report Liver abscess formation is one of the major complications following radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC). Clostridium perfringens is a rare but fatal (mortality rate: 70–100%) organism that could lead to severe sepsis. We presented a case where a 63-year-old woman with diabetes mellitus, hypertension, chronic hepatitis B-related cirrhosis in Child-Pugh class A and HCC with initial TNM stage II who had undergone 2 sessions of transarterial chemoembolization. RFA was performed for 4 small HCC due to poor effect of previous transarterial chemoembolization. However, all 4 treated tumors developed liver abscesses presenting with septic shock within 1 day. Aspirated abscesses and blood culture both yielded C. perfringens infection. After intensive care, optimal intravenous antibiotic, and abscesses aspiration, the patient recovered successfully. All tumors achieved complete response during the follow-up period without local recurrence. The clinical presentations and risk factors of C. perfringens−related liver abscess after RFA will be discussed in this manuscript. S. Karger AG 2021-06-17 /pmc/articles/PMC8261265/ /pubmed/34267637 http://dx.doi.org/10.1159/000517024 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Case Report Wang, Ming-Hung Kuo, Yuan-Hung Yen, Yi-Hao Lu, Sheng-Nan Wang, Jing-Houng Chen, Chien-Hung Hung, Chao-Hung Kee, Kwong-Ming Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case |
title | Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case |
title_full | Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case |
title_fullStr | Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case |
title_full_unstemmed | Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case |
title_short | Hepatic Clostridium Perfringens Abscess Formation after Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: Report of a Rare Case |
title_sort | hepatic clostridium perfringens abscess formation after radiofrequency ablation therapy for hepatocellular carcinoma: report of a rare case |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261265/ https://www.ncbi.nlm.nih.gov/pubmed/34267637 http://dx.doi.org/10.1159/000517024 |
work_keys_str_mv | AT wangminghung hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase AT kuoyuanhung hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase AT yenyihao hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase AT lushengnan hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase AT wangjinghoung hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase AT chenchienhung hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase AT hungchaohung hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase AT keekwongming hepaticclostridiumperfringensabscessformationafterradiofrequencyablationtherapyforhepatocellularcarcinomareportofararecase |